Stock ARTH ARCH THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Arch Therapeutics, Inc.

Equities

ARTH

US03939W2089

Delayed OTC Markets
Other stock markets
 01:58:30 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.18 USD +3.51% Intraday chart for Arch Therapeutics, Inc. +12.38% -83.70%
Feb. 20 Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Feb. 15 Arch Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System
CI
Arch Therapeutics, Inc. Announces Resignation of Jim Sulat as Member of the Board
CI
Arch Therapeutics Announces Appointment of Guy Fish to the Board
CI
Arch Therapeutics, Inc. Appoints Larry Hicks to its Board of Directors
CI
Arch Therapeutics, Inc. Appoints Punit Dhillon as a Director
CI
Arch Therapeutics Appoints Punit Dhillon to Board of Directors
CI
Arch Therapeutics, Inc. Appoints James Sulat as Director
CI
Arch Therapeutics, Inc. Announces Retirement of William M. Cotter as Chief Operating Officer
CI
Arch Therapeutics, Inc. Announces Resignation of Arthur Rosenthal from the Board
CI
Arch Therapeutics, Inc. Announces Executive Changes
CI
Arch Therapeutics, Inc. Announces Executive Changes
CI
Arch Therapeutics, Inc. Appoints William M. Cotter as Chief Operating Officer, Effective July 8, 2013
CI
Arch Therapeutics, Inc. Announces Management Appointments
CI
Arch Therapeutics, Inc. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ARTH Stock
  4. News Arch Therapeutics, Inc.
  5. Insiders